Top compounds associated with response to VLDLR


Feature Type Standardized
Nominal ANOVA
mRNA ELCPK CTRPv2 pan-cancer AAC 0.17 0.0009
mRNA etomoxir CTRPv2 pan-cancer AAC 0.13 0.001
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.1 0.002
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.11 0.002
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.095 0.002
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA staurosporine CTRPv2 pan-cancer AAC 0.23 0.002
Download CSV